Ignite Creation Date:
2025-12-24 @ 5:24 PM
Ignite Modification Date:
2025-12-30 @ 4:53 AM
Study NCT ID:
NCT06108050
Status:
RECRUITING
Last Update Posted:
2025-12-16
First Post:
2023-10-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
Sponsor:
Jazz Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-11-07
Start Date Type:
ACTUAL
Primary Completion Date:
2027-11-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-05-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-10-19
First Submit QC Date:
None
Study First Post Date:
2023-10-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-08
Last Update Post Date:
2025-12-16
Last Update Post Date Type:
ESTIMATED